Consultation Opportunity: Pharmacy Professional Communication Preferences
CPNL is currently inviting feedback on CPNL communications with registered pharmacy professionals. Your feedback will help inform how CPNL delivers communications and engages with you, as well as what information you need from CPNL to support optimal practice.
It is important to us that we understand your communications preferences so that we can ensure that you receive critical regulatory and pharmacy practice information in an accessible and efficient manner.
If you are unable to access the survey by clicking the link, copy and paste the link into your web browser’s address bar.
Please Note: You can leave the survey and resume it later if you use the same computer and the same browser. If you attempt to resume the survey on another computer or using a different browser, you will have to restart the survey from the beginning.
Individual survey responses are anonymous and confidential.
The deadline for submitting your response is Friday, February 6, 2026.
If you have any questions regarding the purpose of the survey or the use of survey data, please contact the Director of Communications, Julie Reddy, at jreddy@cpnl.ca or 709-753-5877 ext. 107.
We appreciate your time and look forward to your feedback.
Update on Pharmacist-Ordered Laboratory Tests Education Program
As noted in the October 2025 issue of The PostScript, Standards of Practice for Pharmacist-Ordered Laboratory Tests have been approved by the CPNL Board of Directors and published on the CPNL website for registered pharmacists to review and to support preparations for integrating the service into practice.
Click the following link for more information: Ordering Laboratory Tests
Work on the development of an education program that meets the requirements of the Standards is nearing completion and is expected to be launched in the coming weeks.
Registered pharmacists will be notified once the program and the associated authorization process are available.
Document Integrity in the Electronic Health Record
Pharmacy professionals play an essential role in the circle of patient care. Factual, consistent, timely, and quality documentation ensures successful patient recordkeeping, enhances the opportunity for collaboration, and supports the principles of patient safety and continuity of care. It is the responsibility of pharmacy professionals to ensure a complete and accurate patient record is maintained, including both the patient’s local and provincial electronic health record (EHR) profiles.
Pharmacy professionals are reminded that the Standards for the Administration of Drug Therapy by Injection or Inhalation require recording both the dispense and the administration of inhalations and injections in the provincial EHR, HEALTHe NL.
If a drug therapy for injection or inhalation is dispensed and administered at your pharmacy, you are required to record both, accordingly, in the Pharmacy Network (or other appropriate regional health authority-approved record), resulting in their inclusion in the EHR. The administration record contains important information that is not contained in the dispense record, such as administration site, dose number, date of next dose, and any adverse reaction information.
Pharmacy professionals should also note that to ensure the completeness of provincial vaccination records, the administration of a vaccine must be recorded in the Pharmacy Network.
Pharmacy professionals are advised to contact the Digital Health division of NL Health Services Service Desk if they have questions about how to properly record the administration of vaccines or other drug therapy for injection or inhalation in the Pharmacy Network.
NLHS Concurrent Addictions Specialized Treatment (CAST) Webinar
The NL Centre on Substance Use invites you to register for their upcoming Service Highlight webinar: NLHS Concurrent Addictions Specialized Treatment (CAST): An Overview of Services, Referrals, and the Role of Occupational Therapy
Date: Wednesday, February 4, 2026
Time: 1:00–2:00 p.m. NDT
Platform: Zoom
This webinar will provide an overview of Concurrent Addictions Specialized Treatment (CAST), an outpatient, community-based counselling program for adults in the metro region experiencing concurrent mental health and substance use concerns. CAST is a specialized, goal-oriented program delivered by a multidisciplinary team including clinical social workers, a clinical psychologist, and a clinical occupational therapist.
Participants will learn about:
Presenters:
Emily Webber, MScOT, OT(R)NL, Occupational Therapist II
Kathlene White, MSW, RSW, Social Work III / Clinical Lead
Target Audience:
This session may be of interest to clinicians, service providers, and others working in mental health and substance use across Newfoundland and Labrador who would like to learn more about CAST services.
Register here: https://nlchi-nl-ca.zoom.us/meeting/register/6oQH3cUNTkWRkJZqzzHpSQ#/registration
NAPRA Consultations: Compounding Standards and Competence
The National Association of Pharmacy Regulatory Authorities (NAPRA) is conducting two public consultations related to sterile and non-sterile compounding.
Thank you to all candidates who submitted an expression of interest.
- Consultation on Model Documents for PRA Use – Non-sterile and Sterile Compounding Standards
- In 2024, NAPRA began a review and update of its suite of model documents on standards of practice for pharmacy compounding and is now seeking additional external input on draft documents.
- The goal of the project is to update the documents to better align with the outcome-based approach taken for other NAPRA model documents, update the content based on current evidence-informed references, address any issues/concerns with the current documents, and ensure the documents reflect current and anticipated future pharmacy practice.
- Consultation on Components for PRA Approach to Compounding Competence
- In December 2025, NAPRA communicated the PRA agreed-upon approach to compounding competence to key interested parties and is now consulting on various components that are required to support PARs in implementing the agreed-upon approach to compounding competence, including:
- guidance for education accreditors
- a national list of qualifications/criteria for assessors
- timelines required for the various steps in the process
- In December 2025, NAPRA communicated the PRA agreed-upon approach to compounding competence to key interested parties and is now consulting on various components that are required to support PARs in implementing the agreed-upon approach to compounding competence, including:
Please click the appropriate links for further details about each consultation, to review the consultation document, and to provide your feedback via the surveys linked in each consultation document. The deadline to provide comments and feedback for either or both consultations is 11:59 p.m. (Eastern) on March 15, 2026.
NLCSU Project Echo NL Cycle 5 Registration Now Open
The Newfoundland and Labrador Centre on Substance Use (NLCSU) Project ECHO NL: Substance Use is a virtual, case-based learning community focused on advancing care and treatment for people who use substances. Sessions are open to a wide range of participants, including peer support workers, social workers, addictions counsellors, licensed practical nurses, registered nurses, pharmacists, nurse practitioners, physicians, other health professionals, and students.
While Project ECHO NL: Substance Use is based in Newfoundland and Labrador, participation is open to providers and learners from across Canada and internationally.
Below is the full Cycle 5 Schedule. Individuals are welcome to register for one or multiple sessions.
Cycle 5 Session Schedule and Registration
Please note that individual session posters, including learning objectives and additional session details, will be shared with the NLCSU distribution list in advance of each session. Anyone who would like to receive these updates can email nlcsu@nlhealthservices.ca to be added to the distribution list.
If you have any questions, please contact NLCSU.ECHO@nlhealthservices.ca.
Invitation to Participate in Study of Impact of Pride Symbols in Community Pharmacy
Researchers from Dalhousie University and the University of Saskatchewan are conducting a study that aims to explore how Pride symbols (e.g., rainbow flags, pronoun pins, brochures) are perceived and displayed in community pharmacy settings across Canada.
If you are a pharmacy manager or owner in Canada, you are invited to complete a short questionnaire (approximately 10 minutes to complete) to help the researchers understand how these symbols can be meaningfully incorporated into pharmacy environments to foster inclusivity for 2SLGBTQIA+ (Two-Spirit, Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, and Asexual) individuals.
The findings will help inform future guidance and professional development for pharmacy teams across Canada.
The survey can be accessed here.
Participation is entirely voluntary, and all responses will remain anonymous. This study has received ethics approval from the Dalhousie University Research Ethics Board (File # 2022-6044).
Pharmacists who have questions about the study or who would like more information should contact:
Kyle John Wilby, PhD kyle.wilby@dal.ca (902.880.0040 ) or
Jason Perepelkin, PhD jason.perepelkin@usask.ca (306.966.6992).
Regular Reminders
Scheduling Appointments with Staff
CPNL staff are here to assist and support you. If you wish to meet with a staff member in person, please call to schedule an appointment before visiting our office. Having details regarding your inquiry will help us appropriately prioritize and prepare to answer your question if we need to collect additional information before calling you back or meeting with you. If you are unable to reach the staff person by phone, please leave a detailed message. Voicemails are regularly checked, and staff members get email alerts when a message is left on their phone line.
Keeping Contact Information Up to Date
Registered pharmacy professionals are responsible for ensuring that the contact information on their registrant profile, including email address and practice site, is accurate at all times. CPNL primarily uses email communication to send newsletters, renewal reminders, practice site assessment information, professional development audit information, calls for interest for committees, and other alerts. If the email address on file is incorrect, important information may be missed and/or disclosed to the wrong person. If your contact information changes, please update your information on file by logging into the Registrant Portal.